Journal of Peking University(Health Sciences) ›› 2014, Vol. 46 ›› Issue (5): 790-793.

• Articles • Previous Articles     Next Articles

Clinical pathological features of small renal cell cancer: a single-center experience on 1 267 cases

YANG Kai-wei, ZHANG Cui-jian, LI Xue-song△, HE Zhi-song, ZHOU Li-qun△   

  1. (Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China)
  • Online:2014-10-18 Published:2014-10-18

Abstract: Objective:To study the characteristics of histopathologic features of small renal carcinoma. Methods: This retrospective study collected the data of renal cell carcinoma from the patients who underwent surgery from January 2002 to June 2012. They were all preoperatively diagnosed as renal cancer by CT scan, and pathologically diagnosed as renal cell carcinoma after surgery with the diameter ≤4 cm. We recorded and analyzed the tumor size, histologic subtype, Fuhrman grading, TNM stage, the existence of tumor vascular invasion, sarcomatoid differentiation, and whether it was multifocal, and then grouped them for comparison. Results: A total of 1 276 patients were included in the study and were analyzed, of whom 306 (24.0%) had small renal cell carcinoma less than 2.0 cm, 526 (41.2%) 2.0-3.0 cm, and 444 (34.8%) bigger than 3.0 cm. Of all the subjects, 1 158 (90.7%) suffered from clear cell carcinoma, 49 (3.8%) papillary carcinoma, 32 (2.5%) chromophobe cell carcinoma, whose distribution was not related with tumor size. Of the ≤2.0 cm and >2.0 cm groups, Furmann grades of G3/4 were 15 (4.9%), 98 (10.1%), respectively (P=0.007). T3a+ stage and above were 1 (0.3%), and 32 (3.3%), respectively (P=0.004). Synchronous distant metastases occurred in 6 patients, all in group >2.0 cm. Tumor sarcomatoid differentiation (0.3% vs. 0.9%), vascular invasion (0.6% vs. 2.1%) and multifocal (1.3% vs. 2.7%) had no significant difference between the two groups. Conclusion:Small renal cell carcinoma with diameter over 2.0 cm are more aggressive, suggesting that renal cancer bigger than 2.0 cm in diameter should not select a nonsurgical treatment.

Key words: Carcinoma, renal cell, Neoplasm staging, Neoplasm metastasis, Urologic surgical procedures

[1] Mingrui WANG,Jun LIU,Liulin XIONG,Luping YU,Hao HU,Kexin XU,Tao XU. Efficacy and safety of mini-track, mini-nephroscopy and mini-ultrasonic probe percutaneous nephrolithotomy for the treatment of 1.5-2.5 cm kidney stones [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 605-609.
[2] Yue WANG,Shuang ZHANG,Hong ZHANG,Li LIANG,Ling XU,Yuan-jia CHENG,Xue-ning DUAN,Yin-hua LIU,Ting LI. Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 853-862.
[3] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[4] Shi-ming ZHAO,Tie-jun YANG,Chun-miao XU,Xiao-feng GUO,Yong-kang MA,Xue-jun CHEN,Xiang LI,Chao-hong HE. Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 701-704.
[5] Xu-chu ZHANG,Jian-hua ZHANG,Rong-fu WANG,Yan FAN,Zhan-li FU,Ping YAN,Guang-yu ZHAO,Yan-xia BAI. Diagnostic value of 18F-FDG PET/CT and tumor markers (CEA, CA19-9, CA24-2) in recurrence and metastasis of postoperative colorectal moderately differentiated adenocarcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1071-1077.
[6] Chen LIANG,Wei-yu ZHANG,Hao HU,Qi WANG,Zhi-wei FANG,Ke-xin XU. Comparison of effectiveness and complications between two different methods of augmentation cystoplasty [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 293-297.
[7] HUANG Zi-xiong, DU Yi-qing, ZHANG Xiao-peng, LIU Shi-jun, XU Tao. Clinical and pathological analysis of renal cell carcinoma bone metastasis [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 811-815.
[8] HUANG Zi-xiong, ZHANG Xiao-peng, DONG Sen, LIU Shi-jun, YANG Rong-li, ZHOU Yu-shi, MA Wei-guo. Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 732-735.
[9] ZHANG Ling-fu, HOU Chun-sheng, GUO Li-mei, TAO Li-yuan, LING Xiao-feng, WANG Li-xin, XU Zhi, XIU Dian-rong. Surgical strategies for treatment of T1b gallbladder cancers diagnosed intraoperatively or postoperatively [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1034-1037.
[10] ZHAO Yi-guo, YANG Xiao-dong, ZHANG Yan-kai, NING Ning, XING Zhao-dong, YE Ying-jiang. #br# Adenocarcinoma in a Meckel’s diverticulum with multiple liver metastases and gastrointestinal hemorrhage: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1095-1097.
[11] WANG Wei, ZHENG Lei, LIU Shu-ming, HUANG Ming-wei, SHI Yan, LV Xiao-ming, ZHANG Jie, ZHANG Jian-guo. Distant metastases of malignant salivary gland carcinoma after treated by 125Ⅰinternal brachy therapy alone [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 547-550.
[12] GUO Fu-xin, JIANG Yu-liang, JI Zhe, PENG Ran, SUN Hai-tao, WANG Jun-jie. 3D printed template-assisted and computed tomography image-guided 125-iodine seed implantation for supraclavicular metastatic tumor: a dosimetric study [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 506-511.
[13] FANG Wei-gang, TIAN Xin-xia. Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP [J]. Journal of Peking University(Health Sciences), 2017, 49(2): 188-195.
[14] YE Xiong-jun, ZHONG Wen-long, XIONG Liu-lin, MA Kai1, XU Tao, HUANG Xiao-bo, WANG Xiao-feng. Retroperitoneoscopic renal pedicle lymphatic disconnection for chyluria via extra-adipose capsule [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 618-621.
[15] QIN Cai-peng,LIU Chun-lei, ZHAO Yan-hui, YIN Hua-qi, DU Yi-qing, HU Feng-zhan, SHENG Zheng-zuo, XU Tao. Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 590-593.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!